✦ LIBER ✦

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

✍ Scribed by E. Curtit; P. Nouyrigat; N. Dohollou; E. Levy; A. Lortholary; J. Gligorov; T. Facchini; D. Jaubert; N. Maille; X. Pivot; V. Grangé; L. Cals

Book ID: 116430856
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 356 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2011.08.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical benefit of pegylated liposo

The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial

✍ Al-Batran, S-E; Bischoff, J; von Minckwitz, G; Atmaca, A; Kleeberg, U; Meuthen, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

The Clinical Benefit of Pegylated Liposo

The Clinical Benefit of Pegylated Liposomal Doxorubicin in Patients With Metastatic Breast Cancer Previously Treated With Conventional Anthracyclines: A Multicentre Phase II Trial

✍ Wolff, A.C. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A multicentre Phase II study of non-pegy

A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer

✍ M. Venturini; C. Bighin; F. Puglisi; N. Olmeo; E. Aitini; G. Colucci; O. Garrone 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Phase I/II study of gemcitabine with peg

Phase I/II study of gemcitabine with pegylated liposomal doxorubicin as first-line therapy in Asian women with metastatic breast cancer

✍ Zee-Wan Wong; Peter Cher-Siang Ang; Balram Chowbay; Nan-Soon Wong; Hui-Ti See; K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 185 KB

A phase I/II trial of non-pegylated lipo

A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer

✍ D. Amadori; C. Milandri; G. Comella; S. Saracchini; S. Salvagni; C. Barone; R. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Phase II trial of pegylated liposomal do

Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group Trial E3198

✍ Antonio C. Wolff; Molin Wang; Hailun Li; Michael R. Pins; Florence J. Pretorius; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 311 KB